Consensus perspectives on quality control and safety strategies for the clinical translation of induced pluripotent stem cell−derived cell therapies

Vladislav Krupalnik, Shin Kawamata, Joanne Mountford, George Muschler, Hiroto Bando, Wanxing Cui, Xiaokui Zhang, Tenneille E. Ludwig, Lise Munsie, Natacha Agabalyan, Terri Gaskell, Anthony Asmar, Deborah Hursh, Masayo Takahashi, Takehiko Kaneko, Bruna Paulsen, Arina Perez, Takako Yamamoto, Massimiliano Gnecchi

Open source

DOI: 10.1016/j.jcyt.2026.102969
Published: 2027-01
Container: Cytotherapy
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jcyt.2026.102969,
  title = {Consensus perspectives on quality control and safety strategies for the clinical translation of induced pluripotent stem cell−derived cell therapies},
  author = {Vladislav Krupalnik and Shin Kawamata and Joanne Mountford and George Muschler and Hiroto Bando and Wanxing Cui and Xiaokui Zhang and Tenneille E. Ludwig and Lise Munsie and Natacha Agabalyan and Terri Gaskell and Anthony Asmar and Deborah Hursh and Masayo Takahashi and Takehiko Kaneko and Bruna Paulsen and Arina Perez and Takako Yamamoto and Massimiliano Gnecchi},
  year = {2027},
  journal = {Cytotherapy},
  doi = {10.1016/j.jcyt.2026.102969},
  url = {https://doi.org/10.1016/j.jcyt.2026.102969}
}

RIS

TY  - JOUR
TI  - Consensus perspectives on quality control and safety strategies for the clinical translation of induced pluripotent stem cell−derived cell therapies
AU  - Vladislav Krupalnik
AU  - Shin Kawamata
AU  - Joanne Mountford
AU  - George Muschler
AU  - Hiroto Bando
AU  - Wanxing Cui
AU  - Xiaokui Zhang
AU  - Tenneille E. Ludwig
AU  - Lise Munsie
AU  - Natacha Agabalyan
AU  - Terri Gaskell
AU  - Anthony Asmar
AU  - Deborah Hursh
AU  - Masayo Takahashi
AU  - Takehiko Kaneko
AU  - Bruna Paulsen
AU  - Arina Perez
AU  - Takako Yamamoto
AU  - Massimiliano Gnecchi
PY  - 2027
JO  - Cytotherapy
DO  - 10.1016/j.jcyt.2026.102969
UR  - https://doi.org/10.1016/j.jcyt.2026.102969
ER  -

APA

Krupalnik, V., Kawamata, S., Mountford, J., Muschler, G., Bando, H., Cui, W., Zhang, X., Ludwig, T. E., Munsie, L., Agabalyan, N., Gaskell, T., Asmar, A., Hursh, D., Takahashi, M., Kaneko, T., Paulsen, B., Perez, A., Yamamoto, T., & Gnecchi, M. (2027). Consensus perspectives on quality control and safety strategies for the clinical translation of induced pluripotent stem cell−derived cell therapies. Cytotherapy. https://doi.org/10.1016/j.jcyt.2026.102969

Source records

crossref · retrieved 2026-11-04T13:23:38.623Z